While direct evidence in inflammatory bowel disease is limited, studies in irritable bowel syndrome show that miR-199 upregulates TRPV1, thereby enhancing visceral pain—an effect that is plausibly relevant to IBD [26]. Here, TRPV1 is linked to inflammatory bowel disease.